Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
XDC Conjugate Drugs
Sort By
Newest First
Sign in
1 / 1
1 / 1
Announcement
Porton Pharma Solutions and Aojin Life Sciences Strategically Collaborate to Advance XDC Conjugate Drugs for Dual IND Filings
Porton Pharma Solutions
PR-12-24-NI-136
Dec 12, 2024
